Skip to Primary Navigation

Skip to main content

FDA updates guide on comms about unapproved use of approved medical products

Image: A sign for the Food And Drug Administration located in Maryland.
Photo: Sarah Silbiger/Getty Images
Julie DiMauro profile image

Julie DiMauro

2 min read

Final guidance clarifies FDA approach and addresses issues the industry raised regarding a draft version.

Last month, the US Food and Drug Administration (FDA) released its latest guidance, Communications from Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products: Questions and Answers. In this final guidance, the FDA describes recommendations for medical product manufacturers intending to disseminate

It

, , , ,

Get full access, free for a month

Start your 28-day free trial to continue reading and access
all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience